Announcements
Sidley Represents SunOpta in US$141 Million Sale of Its Frozen Fruit Assets
October 17, 2023
Sidley represented SunOpta, Inc. (NASDAQ:STKL) (TSX:SOY) in the disposition of certain assets of its frozen fruit operations to Canadian-based frozen food manufacturer, Nature’s Touch. The transaction, valued at US$141 million, included the sale of SunOpta’s primary assets of its frozen fruit business, including its facilities in Edwardsville, Kansas and Jacona, Mexico, and a significant quantity of frozen fruit inventory. SunOpta is a U.S.-based manufacturer of natural, organic, and specialty food products, and the sale finalizes its portfolio optimization that began in 2020.
The Sidley team was led by Alexis A. Cooper (M&A and Private Equity), and includes Brian J. Fahrney, Thomas E. Johnson, David Meehan, Reed M. Kreger, and Scott A. Gregus (M&A and Private Equity); Joshua W. Thompson, Shayona Dhanak, and Jin Cho (Global Finance); James W. Lowe, Edward W. Sharon, and Jason C. Semmes (Antitrust/Competition); Lauren A. Gallagher and P.C. Wang (Employee Benefits and Executive Compensation); Maureen F. Gorsen (Environmental); Elizabeth K. McCloy and Will Otter (Real Estate); Suresh T. Advani and Mitchell Li (Tax); and Anna Remis, Paul Kariyawasam, and Natalie T. Crawford (Technology and Life Sciences Transactions).
The Sidley team was led by Alexis A. Cooper (M&A and Private Equity), and includes Brian J. Fahrney, Thomas E. Johnson, David Meehan, Reed M. Kreger, and Scott A. Gregus (M&A and Private Equity); Joshua W. Thompson, Shayona Dhanak, and Jin Cho (Global Finance); James W. Lowe, Edward W. Sharon, and Jason C. Semmes (Antitrust/Competition); Lauren A. Gallagher and P.C. Wang (Employee Benefits and Executive Compensation); Maureen F. Gorsen (Environmental); Elizabeth K. McCloy and Will Otter (Real Estate); Suresh T. Advani and Mitchell Li (Tax); and Anna Remis, Paul Kariyawasam, and Natalie T. Crawford (Technology and Life Sciences Transactions).
Contacts

Capabilities
Suggested News & Insights
Sidley Represents NextCure in Merger With Avere Therapeutics and Concurrent US$320 Million Private PlacementJuly 17, 2026Sidley Finishes H1 2026 Among Top Three US$1B+ Dealmakers in TexasJuly 16, 2026European Commission Signals Targeted Procedural Simplification of the Foreign Subsidies Regulation – Without Weakening EnforcementJuly 16, 2026Inspection Rights, Internal Affairs, and Personal Jurisdiction: Orchid Global’s Procedural LessonJuly 15, 2026Sidley Advises EMZ Partners on Its Significant Minority Investment in Steinbach & VollmannJuly 13, 2026Sidley Represents Sino Biopharm in an Exclusive License Agreement With AstraZenecaJuly 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory




